Delivery Order SPE2DB20D7061-SPE2DB25FSPK3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,380.20 to AmerisourceBergen Drug Corp for Tubersol 5T Unit/0.1 ML Vial tuberculin skin test antigen. This competitively awarded, firm fixed-price delivery order was executed on August 29, 2025, with an ultimate completion date of September 2, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,179.04 on August 19, 2025, for the supply of Tubersol 5T Unit/0.1 mL vial 5mL tuberculin skin test antigen. This firm fixed price, non-set-aside contract is scheduled for completion by August 20, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,742.90 to supply Tubersol 5T Unit tuberculin skin test vials (0.1 mL, 5 mL format) with an ultimate completion date of June 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,450.96 by the Defense Logistics Agency on July 14, 2025, for the supply of APLISOL 5T Unit/0.1 ML Vial 5ML. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- This firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,446.40 order is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product, with a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on a single award indefinite delivery contract (IDC) valued at up to $999,999,999.00 with DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML. The contract has a ceiling value of $1,709.38 and an ultimate completion date of April 27, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, valued at $1,070.95, with a completion date of February 11, 2025. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,285.14. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of June 25, 2025. This contract is not set-aside and is open to competition....
- This delivery order, awarded on August 29, 2025, represents a $1,728 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain and AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery. The contract, which is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (valued at $999,999,999.00 and extending through December 2026), involves no set-aside designation and was competitively awarded. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $10,473.58 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPK3Delivery Order
This delivery order, awarded on August 27, 2025, to AmerisourceBergen Drug Corp, provides $2,797.86 in firm fixed price pharmaceutical supplies to the Defense Logistics Agency. Specifically, the contract calls for delivery of Tubersol 5T tuberculin skin test units in 0.1 milliliter vials with 5 milliliter capacity to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of August 28, 2025. This award was not issued under any set-aside program and represents a competitively awarded transaction. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime vehicle serves as a comprehensive global pharmaceutical support arrangement enabling the company to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's role as a major pharmaceutical distributor and healthcare solutions provider positions it as a critical vendor for federal medical procurement, with a demonstrated capability to fulfill diverse pharmaceutical requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/27/25 |